BefejeződöttFázis nélkül
An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.
A legfontosabb adatok
- Ki végzi
- GlaxoSmithKline
- Hol
- Austin, Boston, Columbus, Fort Worth, Houston, Kansas City, Lawrenceville, Long Beach, Los Angeles, Marietta, Memphis, Miami, Newark, Philadelphia, Plantation, Richmond, San Francisco, Smyrna és St Louis (Egyesült Államok)Mind a 19 helyszín megnézéseMég 5 másik országban, 25 helyszínen
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 537 fő vett részt
- Kezdés
- 2021. jún. 9.
- Befejezés
- 2024. márc. 14.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Blood sampling
- Anogenital lesion swab collection
- A regiszteradat frissítve
- 2025. március 7.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 9 feltétel megnézéseKevesebb
Ki vehet részt
- Man or woman ≥18 years old
- Written informed consent obtained from the patient prior to performance of any study-specific procedure
- History of at least one episode of HSV-2 genital herpes lesions in the 12 months preceding the screening, and seropositive for HSV-2 as determined by Western blot OR PCR-positive for HSV-2 (newly diagnosed patients)
- Patients who are medically stable in the opinion of the investigator
- Patients who, in the opinion of the investigator, are able to understand and comply with the study requirements (attend regular telephone calls/study site visits/home visits/self-completion of questionnaires, self-swabbing)
- Seronegative for HIV, as determined by laboratory testing. Patients documented to be positive to HIV will not be eligible for study participation
Ki nem vehet részt
- Prior receipt of a vaccine or candidate vaccine containing HSV antigens
- Other genital tract disorders or sexually transmitted diseases that may interfere with the assessment of the study (as per investigator's judgement)
- Immunocompromised patients, as per medical history and investigator judgement
Helyszínek itt: Egyesült Államok
Még 5 másik országban, 25 helyszínen
- Austin, TexasHospital not named in the registry
- Boston, MassachusettsHospital not named in the registry
- Columbus, OhioHospital not named in the registry
- Fort Worth, TexasHospital not named in the registry
- Houston, TexasHospital not named in the registry
- Kansas City, MissouriHospital not named in the registry
- Lawrenceville, GeorgiaHospital not named in the registry
- Long Beach, CaliforniaHospital not named in the registry
- Los Angeles, CaliforniaHospital not named in the registry
- Marietta, GeorgiaHospital not named in the registry
- Memphis, TennesseeHospital not named in the registry
- Miami, FloridaHospital not named in the registry
- Newark, DelawareHospital not named in the registry
- Philadelphia, PennsylvaniaHospital not named in the registry
- Plantation, FloridaHospital not named in the registry
- Richmond, VirginiaHospital not named in the registry
- San Francisco, CaliforniaHospital not named in the registry
- Smyrna, GeorgiaHospital not named in the registry
- St Louis, MissouriHospital not named in the registry
A vizsgálatról
Mit akar kideríteni a vizsgálat
The aim of this study is to assess performance of using healthcare tools to understand genital Herpes Simplex Virus-2 (HSV-2) in patients ≥ 18 years of age in the United States and Europe.
A teljes eredeti leírásKevesebb
More specifically, the study aims to evaluate patient-reported outcome and quality-of-life endpoints as well as the performance study procedures in a decentralised setting. Ultimately, this study will allow generating additional real-world evidence (RWE) on patterns of recurrences and other key parameters.
A vizsgálat csoportja
- Overall Study Group
Patients aged 18 years old or above, with HSV-2 genital herpes, who are recruited in specific community settings in the United States and in Europe.
Kezelés: Blood sampling és Anogenital lesion swab collection
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Descriptive, Prospective, Multi-country, Multicentre Study to Assess Performance of Genital Herpes Simplex Virus-2 (HSV-2) Related Disease Endpoints Based on Patient-reported Health Outcomes, Self-swabbing Collected Via Decentralised Approach in Patients ≥ 18 Years of Age in the United States and Europe.
- A regiszteradat frissítve
- 2025. március 7.